Fig. 1From: The soluble VCAM-1 level is a potential biomarker predicting severe acute graft versus host disease after allogeneic hematopoietic cell transplantationCumulative incidence of (A) all grades of acute graft versus host disease (GVHD) and (B) extensive chronic GVHDBack to article page